VistaGen Therapeutics, Inc.
VTGN
$2.22
-$0.12-5.13%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -30.02% | 159.46% | 1,026.18% | 616.23% | 405.48% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -6.71% | 70.10% | 136.97% | 78.55% | 224.63% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 10.45% | -81.83% |
| Total Current Assets | -29.80% | 155.78% | 857.25% | 589.28% | 391.66% |
|
|
|||||
| Total Current Assets | -29.80% | 155.78% | 857.25% | 589.28% | 391.66% |
| Net Property, Plant & Equipment | -20.59% | -17.65% | -16.64% | -18.50% | -18.11% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -17.09% | -20.99% | -37.13% | -10.92% | -22.93% |
| Total Assets | -29.57% | 142.91% | 655.36% | 486.34% | 341.18% |
|
|
|||||
| Total Accounts Payable | -40.18% | -45.21% | -25.52% | -37.44% | 8.64% |
| Total Accrued Expenses | 4,129.70% | 1,203.83% | 409.54% | 180.78% | -88.09% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.63% | 1.18% | 12.77% | 13.17% | 13.43% |
| Total Finance Division Other Current Liabilities | 42.39% | 211.22% | 221.43% | 10.78% | 147.48% |
| Total Other Current Liabilities | 42.39% | 211.22% | 221.43% | 10.78% | 147.48% |
| Total Current Liabilities | 131.02% | 158.57% | 54.01% | 12.00% | -2.87% |
|
|
|||||
| Total Current Liabilities | 131.02% | 158.57% | 54.01% | 12.00% | -2.87% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -35.44% | -31.79% | -28.75% | -25.94% | -23.75% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -76.10% | -59.00% | -49.18% | 15.51% | -23.79% |
| Total Liabilities | 43.71% | 45.36% | 6.86% | 3.97% | -13.85% |
|
|
|||||
| Common Stock & APIC | 1.08% | 25.50% | 38.06% | 38.37% | 39.70% |
| Retained Earnings | -13.64% | -11.63% | -9.95% | -8.98% | -10.19% |
| Treasury Stock & Other | 0.28% | 0.56% | 0.05% | 0.00% | 0.00% |
| Total Common Equity | -34.20% | 160.83% | 1,430.19% | 846.08% | 496.31% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -34.20% | 160.83% | 1,430.19% | 846.08% | 496.31% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -34.20% | 160.83% | 1,430.19% | 846.08% | 496.31% |
|
|
|||||